Clinical Trial Update: Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

View source ↗

Summary

An observational safety and effectiveness study update evaluating an adjuvanted Swine-origin A (H1N1) pandemic subunit egg-derived vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza H1n1

Drugs mentioned

• Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Influenza A (H1N1) | Status: COMPLETED